Somatic mutations in BCL-2 in FL are often associated with transformation of this indolent disease to more aggressive diffuse large B cell lymphoma (DLBCL) and decreased patient survival (31). The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.